BioGaia Company Review & Valuation BIOG-B

About BioGaia AB

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates in Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a dairy product. The Other segment provides animal health products. The company offers its products in the areas of baby and child care, including infantile colic, constipation, regurgitation, functional abdominal pain, and diarrhoea; gut health comprising diarrhoea and constipation; gastrointestinal health consisting of Helicobacter pylori–the gastric ulcer bacterium; and oral health, including gingivitis and periodontitis, caries, and halitosis. The company offers its products under the brand name of BioGaia through drug stores and pharmacies. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Primary Stock Exchange Listings

Ticker Symbol:

BIOG-B

Nasdaq First North Growth Market
Sweden

Stock Price

Performance

Registration required

Please login or create a free account to view all available contents of this section.

Create Account

Health Check

Registration required

Please login or create a free account to view all available contents of this section.

Create Account

Financial Reports

Registration required

Please login or create a free account to view all available contents of this section.

Create Account

Similar Companies

↑ back to top